Literature DB >> 1978774

Vitreous amyloidosis associated with homozygosity for the transthyretin methionine-30 gene.

O Sandgren1, G Holmgren, E Lundgren.   

Abstract

Familial amyloidotic polyneuropathy is an autosomal dominant inherited disorder. Biochemical studies have revealed that the amyloid protein in familial amyloidotic polyneuropathy of Japanese, Swedish, and Portuguese origin mainly consists of a variant transthyretin with one amino acid substitution of methionine for valine at position 30, termed TTR met-30. In five Swedish patients with familial amyloidotic polyneuropathy we diagnosed homozygosity for the TTR met-30 gene using restriction fragment length polymorphism analysis. The homozygous individuals did not show more severe systemic symptoms or earlier onset than heterozygotes for the TTR met-30 gene. The only clinical difference was the presence of vitreous opacities in all homozygous patients.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1978774     DOI: 10.1001/archopht.1990.01070130086036

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  5 in total

1.  [Bilateral vitreous opacities].

Authors:  M J M Groh; U Schönherr
Journal:  Ophthalmologe       Date:  2002-03       Impact factor: 1.059

2.  Ocular manifestations of familial amyloidotic polyneuropathy type I: long-term follow up.

Authors:  E Ando; Y Ando; R Okamura; M Uchino; M Ando; A Negi
Journal:  Br J Ophthalmol       Date:  1997-04       Impact factor: 4.638

3.  Comparison of amyloid deposition in two lines of transgenic mouse that model familial amyloidotic polyneuropathy, type I.

Authors:  Y Takaoka; F Tashiro; S Yi; S Maeda; K Shimada; K Takahashi; Y Sakaki; K Yamamura
Journal:  Transgenic Res       Date:  1997-07       Impact factor: 2.788

4.  Modifications of transthyretin in amyloid fibrils: analysis of amyloid from homozygous and heterozygous individuals with the Met30 mutation.

Authors:  C Thylén; J Wahlqvist; E Haettner; O Sandgren; G Holmgren; E Lundgren
Journal:  EMBO J       Date:  1993-02       Impact factor: 11.598

5.  Structure of Met30 variant of transthyretin and its amyloidogenic implications.

Authors:  C J Terry; A M Damas; P Oliveira; M J Saraiva; I L Alves; P P Costa; P M Matias; Y Sakaki; C C Blake
Journal:  EMBO J       Date:  1993-02       Impact factor: 11.598

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.